Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

被引：0
作者：
F. J. Lavalle-González
A. Januszewicz
J. Davidson
C. Tong
R. Qiu
W. Canovatchel
G. Meininger
机构：
[1] Universidad Autonóma de Nuevo León,Endocrinology and Internal Medicine Department
[2] Institute of Cardiology,Department of Hypertension
[3] University of Texas Southwestern Medical School,Department of Medicine
[4] Janssen Research & Development,undefined
[5] LLC,undefined
来源：
Diabetologia | 2013年 / 56卷
关键词：
Canagliflozin; Metformin; Sitagliptin; Sodium glucose co-transporter 2 (SGLT2) inhibitor; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2582 / 2592
页数：10
相关论文
共 50 条
  • [31] Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial
    Fulcher, Greg
    Matthews, David R.
    Perkovic, Vlado
    de Zeeuw, Dick
    Mahaffey, Kenneth W.
    Weiss, Robert
    Rosenstock, Julio
    Capuano, George
    Desai, Mehul
    Shaw, Wayne
    Vercruysse, Frank
    Meininger, Gary
    Neal, Bruce
    [J]. DIABETES THERAPY, 2015, 6 (03) : 289 - 302
  • [32] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Commentary
    Salsali, Afshin
    Pratley, Richard E.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 450 - 451
  • [33] EFFICACY AND SAFETY OF CANAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS OF DIFFERENT ETHNICITY
    Davidson, Jaime A.
    Aguilar, Richard
    Lavalle Gonzalez, Fernando J.
    Trujillo, Angelina
    Alba, Maria
    Vijapurkar, Ujjwala
    Meininger, Gary
    [J]. ETHNICITY & DISEASE, 2016, 26 (02) : 221 - 228
  • [34] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
    Raz, I.
    Hanefeld, M.
    Xu, L.
    Caria, C.
    Williams-Herman, D.
    Khatami, H.
    [J]. DIABETOLOGIA, 2006, 49 (11) : 2564 - 2571
  • [35] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
    I. Raz
    M. Hanefeld
    L. Xu
    C. Caria
    D. Williams-Herman
    H. Khatami
    [J]. Diabetologia, 2006, 49 : 2564 - 2571
  • [36] Efficacy and safety of the addition of ertugliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sitagliptin: The VERTIS SITA2 placebo-controlled randomized study
    Dagogo-Jack, Samuel
    Liu, Jie
    Eldor, Roy
    Amorin, Guillermo
    Johnson, Jeremy
    Hille, Darcy
    Liao, Yuqin
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (03) : 530 - 540
  • [37] The efficacy and safety of canagliflozin across racial groups in patients with type 2 diabetes mellitus
    Gavin, James R., III
    Davies, Melanie J.
    Davies, Michael
    Vijapurkar, Ujjwala
    Alba, Maria
    Meininger, Gary
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (09) : 1693 - 1702
  • [38] Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
    Ametov, A. S.
    Pakus, E. N.
    [J]. DIABETES MELLITUS, 2010, 13 (03): : 62 - 65
  • [39] A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Yan, Xiaoguang
    Li, Jifang
    Cheng, Zhifeng
    Zhang, Lili
    Tian, Junhang
    Li, Ping
    Bai, Jie
    Xie, Daosheng
    Zhao, Jiahong
    Ding, Juping
    Yu, Qiang
    Wang, Tong
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (12) : 3788 - 3797
  • [40] Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
    Vilsboll, T.
    Rosenstock, J.
    Yki-Jarvinen, H.
    Cefalu, W. T.
    Chen, Y.
    Luo, E.
    Musser, B.
    Andryuk, P. J.
    Ling, Y.
    Kaufman, K. D.
    Amatruda, J. M.
    Engel, S. S.
    Katz, L.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (02) : 167 - 177
12345